Skip to main content

Advertisement

Table 6 Summary of clinicopathological data of 76 ovarian cancer patients

From: Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients

  Ovarian cancer ( n= 76)
Age at diagnosis (years)  
  Median 54
  Range 18–90
Stage  
  FIGO (I–II) 27
  FIGO (III–VI) 49
Grade  
  I 13
  II 16
  III 47
Pathological type  
  Serous 48
  Mucinous 23
  Endometroid 5
Median survival (months)  
  PFS 11.51
  OS 17.42
  1. PFS progression-free survival, OS overall survival.